Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Xenobiotica ; 50(4): 371-379, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31192749

RESUMO

1. Numerous tacrolimus population pharmacokinetic (PPK) models in pediatric liver transplantation patients have been established to define an optimal dose schedule. However, the applicability of extrapolating these PPK models to our clinical center remains unknown. The goals of the present study was to evaluate model external predictiveness and establish a new model applicable to traditional therapeutic drug monitoring data.2. Published PPK models were collected from the literature and assessed using our real-world dataset including 41 pediatric liver transplantation patients via the individual prediction error method. The establishment of a new model was characterized using non-linear mixed-effects modeling.3. Nine published pediatric liver transplantation PPK models were identified, three of which could be applied to our real-world dataset. However, these models were dissatisfactory in terms of individual prediction error and hence, inadequate for extrapolation. Finally, a new model applicable to our real-world dataset was established as follows: CL/F = 22.9 × (WT/70)0.75 × (1 - WZ × 0.264) × (1 - FCZ × 0.338) × (1 + ASPI × 0.281) × (POD/41)0.0486 L/h; V/F = 906 × (WT/70) L. Where WT, WZ, FCZ, ASPI and POD were weight, Wuzhi capsule, fluconazole, aspirin and post-transplantation day, respectively. In conclusion, published models were inadequate for application to our real-world dataset. The present study produced a new model applicable to our real-world study data.


Assuntos
Imunossupressores/farmacocinética , Transplante de Fígado , Modelos Estatísticos , Tacrolimo/farmacocinética , Criança , Interações Medicamentosas , Feminino , Humanos , Masculino , Modelos Biológicos
2.
J Affect Disord ; 335: 484-492, 2023 08 15.
Artigo em Inglês | MEDLINE | ID: mdl-37201900

RESUMO

INTRODUCTION: Ketamine intravenous therapy (KIT) appears effective for treating depression in controlled trials testing a short series of infusions. A rapidly proliferating number of clinics offer KIT for depression and anxiety, using protocols without a strong evidence basis. Controlled comparison of mood and anxiety from real-world KIT clinics, and the stability of outcomes, is lacking. METHODS: We performed a retrospective controlled analysis on patients treated with KIT in ten community clinics across the US, between 08/2017-03/2020. Depression and anxiety symptoms were evaluated using the Quick Inventory of Depressive Symptomatology-Self Report 16-item (QIDS) and the Generalized Anxiety Disorder 7-item (GAD-7) scales, respectively. Comparison data sets from patients who did not undergo KIT were obtained from previously published real-world studies. RESULTS: Of 2758 patients treated, 714 and 836 met criteria for analysis of KIT induction and maintenance outcomes, respectively. Patients exhibited significant and concordant reduction in both anxiety and depression symptoms after induction (Cohen's d = -1.17 and d = -1.56, respectively). Compared to two external datasets of KIT-naive depressed patients or patients starting standard antidepressant therapy, KIT patients experienced a significantly greater reduction in depression symptoms at eight weeks (Cohen's d = -1.03 and d = -0.62 respectively). Furthermore, we identified a subpopulation of late-responders. During maintenance, up to a year post-induction, increases in symptoms were minimal. LIMITATIONS: Due to the retrospective nature of the analyses, interpreting this dataset is limited by incomplete patient information and sample attrition. CONCLUSIONS: KIT treatment elicited robust symptomatic relief that remained stable up to one year of follow-up.


Assuntos
Ketamina , Humanos , Depressão/tratamento farmacológico , Estudos Retrospectivos , Transtornos de Ansiedade/tratamento farmacológico , Ansiedade/tratamento farmacológico
3.
Front Digit Health ; 5: 1261057, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38178925

RESUMO

Background & motivation: Household chaos is an established risk factor for child development. However, current methods for measuring household chaos rely on parent surveys, meaning existing research efforts cannot disentangle potentially dynamic bidirectional relations between high chaos environments and child behavior problems. Proposed approach: We train and make publicly available a classifier to provide objective, high-resolution predictions of household chaos from real-world child-worn audio recordings. To do so, we collect and annotate a novel dataset of ground-truth auditory chaos labels compiled from over 411 h of daylong recordings collected via audio recorders worn by N=22 infants in their homes. We leverage an existing sound event classifier to identify candidate high chaos segments, increasing annotation efficiency 8.32× relative to random sampling. Result: Our best-performing model successfully classifies four levels of real-world household auditory chaos with a macro F1 score of 0.701 (Precision: 0.705, Recall: 0.702) and a weighted F1 score of 0.679 (Precision: 0.685, Recall: 0.680). Significance: In future work, high-resolution objective chaos predictions from our model can be leveraged for basic science and intervention, including testing theorized mechanisms by which chaos affects children's cognition and behavior. Additionally, to facilitate further model development we make publicly available the first and largest balanced annotated audio dataset of real-world household chaos.

4.
Artigo em Inglês | MEDLINE | ID: mdl-36311383

RESUMO

Most existing cry detection models have been tested with data collected in controlled settings. Thus, the extent to which they generalize to noisy and lived environments is unclear. In this paper, we evaluate several established machine learning approaches including a model leveraging both deep spectrum and acoustic features. This model was able to recognize crying events with F1 score 0.613 (Precision: 0.672, Recall: 0.552), showing improved external validity over existing methods at cry detection in everyday real-world settings. As part of our evaluation, we collect and annotate a novel dataset of infant crying compiled from over 780 hours of labeled real-world audio data, captured via recorders worn by infants in their homes, which we make publicly available. Our findings confirm that a cry detection model trained on in-lab data underperforms when presented with real-world data (in-lab test F1: 0.656, real-world test F1: 0.236), highlighting the value of our new dataset and model.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA